Point View Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$341K Hold
2,018
0.14% 189
2020
Q3
$299K Sell
2,018
-67
-3% -$10.4K 0.14% 192
2020
Q2
$342K Sell
2,085
-88
-4% -$13.5K 0.16% 176
2020
Q1
$301K Sell
2,173
-1,053
-33% -$145K 0.16% 177
2019
Q4
$424K Buy
3,226
+1,053
+48% +$122K 0.18% 168
2019
Q3
$243K Sell
2,173
-57
-3% -$6.35K 0.11% 221
2019
Q2
$247K Sell
2,230
-24
-1% -$2.83K 0.11% 220
2019
Q1
$292K Sell
2,254
-14
-0.6% -$1.7K 0.13% 196
2018
Q4
$262K Hold
2,268
0.13% 195
2018
Q3
$243K Buy
+2,268
New +$227K 0.11% 220
2017
Q4
Sell
-2,411
Closed -$207K 263
2017
Q3
$207K Sell
2,411
-197
-8% -$16.2K 0.1% 229
2017
Q2
$215K Buy
+2,608
New +$213K 0.11% 220
2015
Q4
Sell
-2,431
Closed -$203K 220
2015
Q3
$203K Sell
2,431
-200
-8% -$16.9K 0.16% 167
2015
Q2
$220K Buy
+2,631
New +$200K 0.17% 166

Other funds holding LLY

Point View Wealth Management's LLY Position: Q4 2020 in Review

Point View Wealth Management held its Eli Lilly (LLY) position steady in Q4 2020 at 2,018 shares worth $341K. The position accounts for 0.14% of the portfolio, ranked #189.

Point View Wealth Management first reported a position in LLY in Q2 2015 and has held it in 14 quarters since. The position peaked at $424K in Q4 2019. 1,887 funds tracked by Wall St. Rank hold LLY as of Q4 2020.

  • Point View Wealth Management held 2,018 shares of Eli Lilly worth $341K as of Q4 2020.
  • Point View Wealth Management left its Eli Lilly share count unchanged in Q4 2020.
  • Eli Lilly made up 0.14% of Point View Wealth Management's portfolio in Q4 2020, its #189 holding.
  • Point View Wealth Management first reported a position in Eli Lilly in Q2 2015 and has held it in 14 quarters since.
  • Point View Wealth Management's Eli Lilly position peaked at $424K in Q4 2019.
  • 1,887 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2020.

Based on Point View Wealth Management's 13F filing for Q4 2020, filed 8 Feb 2021.